SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Jeppesen Jorgen)
 

Search: WFRF:(Jeppesen Jorgen) > Masked Hypertension...

Masked Hypertension in Diabetes Mellitus Treatment Implications for Clinical Practice

Franklin, Stanley S. (author)
Thijs, Lutgarde (author)
Li, Yan (author)
show more...
Hansen, Tine W. (author)
Boggia, Jose (author)
Liu, Yanping (author)
Asayama, Kei (author)
Björklund-Bodegard, Kristina (author)
Uppsala universitet,Geriatrik
Ohkubo, Takayoshi (author)
Jeppesen, Jorgen (author)
Torp-Pedersen, Christian (author)
Dolan, Eamon (author)
Kuznetsova, Tatiana (author)
Stolarz-Skrzypek, Katarzyna (author)
Tikhonoff, Valerie (author)
Malyutina, Sofia (author)
Casiglia, Edoardo (author)
Nikitin, Yuri (author)
Lind, Lars (author)
Uppsala universitet,Kardiovaskulär epidemiologi
Sandoya, Edgardo (author)
Kawecka-Jaszcz, Kalina (author)
Filipovsky, Jan (author)
Imai, Yutaka (author)
Wang, Jiguang (author)
Ibsen, Hans (author)
O'Brien, Eoin (author)
Staessen, Jan A. (author)
show less...
 (creator_code:org_t)
2013
2013
English.
In: Hypertension. - 0194-911X .- 1524-4563. ; 61:5, s. 964-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Although distinguishing features of masked hypertension in diabetics are well known, the significance of antihypertensive treatment on clinical practice decisions has not been fully explored. We analyzed 9691 subjects from the population-based 11-country International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes. Prevalence of masked hypertension in untreated normotensive participants was higher (P<0.0001) among 229 diabetics (29.3%, n=67) than among 5486 nondiabetics (18.8%, n=1031). Over a median of 11.0 years of follow-up, the adjusted risk for a composite cardiovascular end point in untreated diabetic-masked hypertensives tended to be higher than in normotensives (hazard rate [HR], 1.96; 95% confidence interval [CI], 0.97-3.97; P=0.059), similar to untreated stage 1 hypertensives (HR, 1.07; CI, 0.58-1.98; P=0.82), but less than stage 2 hypertensives (HR, 0.53; CI, 0.29-0.99; P=0.048). In contrast, cardiovascular risk was not significantly different in antihypertensive-treated diabetic-masked hypertensives, as compared with the normotensive comparator group (HR, 1.13; CI, 0.54-2.35; P=0.75), stage 1 hypertensives (HR, 0.91; CI, 0.49-1.69; P=0.76), and stage 2 hypertensives (HR, 0.65; CI, 0.35-1.20; P=0.17). In the untreated diabetic-masked hypertensive population, mean conventional systolic/diastolic blood pressure was 129.2 +/- 8.0/76.0 +/- 7.3 mm Hg, and mean daytime systolic/diastolic blood pressure 141.5 +/- 9.1/83.7 +/- 6.5 mm Hg. In conclusion, masked hypertension occurred in 29% of untreated diabetics, had comparable cardiovascular risk as stage 1 hypertension, and would require considerable reduction in conventional blood pressure to reach daytime ambulatory treatment goal. Importantly, many hypertensive diabetics when receiving antihypertensive therapy can present with normalized conventional and elevated ambulatory blood pressure that mimics masked hypertension.

Keyword

ambulatory blood pressure
conventional blood pressure
diabetes mellitus
masked hypertension
population study

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view